指南与共识重症综合管理与镇静镇痛

基于处理脑电图监测指导危重症成人镇静:国际专家小组共识建议

Processed Electroencephalogram-Based Monitoring to Guide Sedation in Critically Ill Adult Patients: Recommendations from an International Expert Panel-Based Consensus.
指南 / 共识 · Neurocrit Care · 2022-07-27
一句话结论国际专家小组共识推荐:所有无法临床评估镇静深度的镇静患者(瘫痪或非瘫痪),经培训后可从额部处理脑电图监测中获益(强共识)。

该共识由21名神经重症与神经麻醉领域的国际多学科专家组成小组,围绕脑电图监测技术、患者选择、监测仪使用、能力与培训四个领域提出问题与陈述,采用德尔菲法迭代形成最终陈述,按中位评分和分歧指数分级。小组认为额部处理脑电图(含连续彩色密度频谱图)足以监测镇静水平(强共识),并推荐所有无法临床评估的镇静患者(瘫痪或非瘫痪)在ICU人员完成专门培训后接受镇静深度监测(强共识)。共识同时指出需打破知识缺乏、长时间镇静验证、不同脑电分析算法监测仪间的标准化及经济问题等障碍,并认为ICU使用镇静深度监测的证据仍 scarce,需进一步研究。

要点

  • 额部处理脑电图(含连续彩色密度频谱图)被认为足以监测镇静水平(强共识)。
  • 推荐所有无法临床评估的镇静患者(瘫痪或非瘫痪)接受镇静深度监测(强共识)。
  • 实施前ICU人员须完成专门培训项目(强共识)。
  • 需打破的障碍包括知识缺乏、长时间镇静的验证、不同脑电分析算法监测仪间的标准化及经济问题。
  • ICU使用镇静深度监测的证据仍 scarce,需进一步研究以明确处理脑电图监测的获益。

适用人群与场景

  • ICU内接受镇静的成人患者,包括瘫痪或非瘫痪、无法进行临床评估者。

处置流程与药物剂量

  • 推荐所有无法临床评估的镇静患者(瘫痪或非瘫痪)接受镇静深度监测(强共识),前提是ICU人员已完成专门培训项目。
  • 额部处理脑电图(含连续彩色密度频谱图)被认为足以监测镇静水平(强共识)。

研究设计与关键结果

  • 由21名参与ICU患者镇静深度监测的神经重症与神经麻醉专家组成国际多学科小组,围绕脑电图监测技术、患者选择、监测仪使用、能力与培训四个领域创建问题与陈述,采用德尔菲法迭代形成最终陈述。
  • 陈述按中位评分分类:高度适当或高度不适当(中位评分≥8)、适当(中位评分≥7但<8)、不确定(中位评分<7),并区分强分歧指数(DI<0.5)或弱分歧指数(DI≥0.5但<1)共识。
  • 小组认为额部处理脑电图(含连续彩色密度频谱图)足以监测镇静水平(强共识)。
  • 小组推荐所有无法临床评估的镇静患者(瘫痪或非瘫痪)在ICU人员完成专门培训项目后接受镇静深度监测(强共识)。
  • 需打破的障碍包括知识缺乏、长时间镇静的验证、基于不同脑电分析算法的监测仪间标准化及经济问题。

证据类型、等级与局限

  • 证据类型:国际专家小组基于德尔菲法的共识。
  • 共识分级:高度适当或高度不适当(中位评分≥8)、适当(中位评分≥7但<8)、不确定(中位评分<7);强分歧指数(DI<0.5)或弱分歧指数(DI≥0.5但<1)。
  • 局限:原文指出ICU使用镇静深度监测的证据仍 scarce,需进一步研究以更好明确处理脑电图监测的获益。

对床旁实践的改变

  • 对无法临床评估镇静深度的ICU成人患者(瘫痪或非瘫痪),专家小组推荐在ICU人员完成专门培训后使用额部处理脑电图(含连续彩色密度频谱图)监测镇静水平(强共识)。
  • 实施前需克服知识缺乏、长时间镇静验证不足、不同脑电分析算法监测仪间缺乏标准化及经济问题等障碍。

指南或共识出处

  • 国际专家小组共识(Neurocrit Care):基于处理脑电图监测指导危重症成人镇静建议。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The use of processed electroencephalography (pEEG) for depth of sedation (DOS) monitoring is increasing in anesthesia; however, how to use of this type of monitoring for critical care adult patients within the intensive care unit (ICU) remains unclear.

METHODS: A multidisciplinary panel of international experts consisting of 21 clinicians involved in monitoring DOS in ICU patients was carefully selected on the basis of their expertise in neurocritical care and neuroanesthesiology. Panelists were assigned four domains (techniques for electroencephalography [EEG] monitoring, patient selection, use of the EEG monitors, competency, and training the principles of pEEG monitoring) from which a list of questions and statements was created to be addressed. A Delphi method based on iterative approach was used to produce the final statements. Statements were classified as highly appropriate or highly inappropriate (median rating ≥ 8), appropriate (median rating ≥ 7 but < 8), or uncertain (median rating < 7) and with a strong disagreement index (DI) (DI < 0.5) or weak DI (DI ≥ 0.5 but < 1) consensus.

RESULTS: According to the statements evaluated by the panel, frontal pEEG (which includes a continuous colored density spectrogram) has been considered adequate to monitor the level of sedation (strong consensus), and it is recommended by the panel that all sedated patients (paralyzed or nonparalyzed) unfit for clinical evaluation would benefit from DOS monitoring (strong consensus) after a specific training program has been performed by the ICU staff. To cover the gap between knowledge/rational and routine application, some barriers must be broken, including lack of knowledge, validation for prolonged sedation, standardization between monitors based on different EEG analysis algorithms, and economic issues.

CONCLUSIONS: Evidence on using DOS monitors in ICU is still scarce, and further research is required to better define the benefits of using pEEG. This consensus highlights that some critically ill patients may benefit from this type of neuromonitoring.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Rasulo FA, Hopkins P, Lobo FA, et al. Processed Electroencephalogram-Based Monitoring to Guide Sedation in Critically Ill Adult Patients: Recommendations from an International Expert Panel-Based Consensus. Neurocrit Care. 2022. PMID: 35896766. doi:10.1007/s12028-022-01565-5

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。